Live Cell Imaging Market

Live Cell Imaging Market Research, 2034

Live Cell Imaging Market to surpass USD 3.67 billion by 2030 from USD 1.7 billion in 2018 at a CAGR of 8.52% throughout the forecast period, i.e., 2019-30.

In an in-vivo environment, Live-Cell Imaging is a study that includes real-time observation and measurement of Live-Cells. These Live-Cells are observed under screening systems or microscopes. It offers an in-depth study of cells' biological functions and pathways. Live-cell imaging has allowed researchers and observers at the molecular level to image cellular activities. In various fields such as molecular biology, microbiology, immunology, neurology, developmental biology, stem cell biology, and others, the study is accepted by several researchers around the world. Live-cell imaging is the method of using images obtained from imaging systems such as high content screening systems and microscopes to study live cells.

Market Highlights

The live Cell Imaging Market is expected to project a notable CAGR of 8.52% in 2030.

Live Cell Imaging Market to surpass USD 3.67 billion by 2030 from USD 1.7 billion in 2018 at a CAGR of 8.52% throughout the forecast period, i.e., 2019-30. Due to its advantage of providing a detailed study of the cells, live-cell imaging has gained significant attention in the market. Growing research activities around the world have prompted this strategy to be adopted. The market has been boosted by heavy research work to develop new drugs. The demand for live-cell imaging has also been fueled by increasing incidences of cancer patients and other chronic illnesses. Government funding for the discovery of new drugs has acted as one of the market drivers. Increasing chronic diseases related to age and lifestyle also drive healthcare demand and spending. Due to urbanization, sedentary lifestyles, changing diets, increasing levels of obesity, and widespread access to tobacco products, cancer, and heart diseases are becoming the main causes of death in developing markets.

Live Cell Imaging Market: Segments

Software segment to grow with the highest CAGR of 6.32% during 2019-30

Live Cell Imaging Market is segmented by product as equipment, consumables, and software. The greater market share of XX% in 2018 was accounted for by the equipment Live Cell Imaging segment of the Live Cell Imaging market which was followed by consumables. Microscopes, cell analyzers, image capturing systems, and standalone systems are part of the equipment segment. Consumables play a significant role in optimizing the results produced. For time-lapse imaging in which the cells are exposed for a long duration, the optimal dye, probes, and medium are critical. The strength of cells may be adversely influenced by the wrong choice of medium. Many players in the industry are active in the market, such as Thermo Fisher and Enzium Inc. The overall industry trend is shifting towards automation, systems integration, and the maximization of microscope data generation. This shift has resulted from the increasing use of live-cell imaging among cell biologists to understand the fundamental nature of cell function and structure.

Stem Cell & Drug Discovery Segment to grow with the highest CAGR of 8.52% during 2019-30

Live Cell Imaging Market is segmented by Application into cell biology, developmental biology, stem cell & drug discovery, and others. Cell biology dominated the application segment due to the rising number of researchers working on molecular interaction networks. Innovations such as filter techniques and advanced illumination devices further enable the procedure. Live-cell imaging is used by cell biologists to understand basic cellular structures and their tissue-level interaction. To further boost the market, advantages such as clarity of structural components and spatial heterogeneity of a cell offered by live-cell imaging are anticipated. Because of the use of live-cell imaging in observing cell embryogenesis and studying the physiological state of the cell, developmental biology has also closely followed cell biology in terms of application. It allows researchers throughout the developmental process to view the activity and proliferation of cells.

Live Cell Imaging Market: Market Dynamics

Drivers

Rising Prevalence of Chronic Disease

Global demand for live-cell imaging is largely affected by the increasing incidence of chronic diseases and the corresponding need for quick diagnostic techniques. The availability of accurate and precise live-cell imaging techniques also helps speed up the processes of drug discovery and other biotechnology research. In the future, growth in expenditure and funding for the development of advanced cell imaging is also expected to boost the market for live-cell imaging. Collaborations between market players and research and academic institutions for the development and introduction of breakthrough products have recently gained pace. To strengthen their stronghold in the market, small players are increasingly acquired by large incumbents for the procurement of breakthrough technologies.

Government Funding for Cell-based Research

Over the forthcoming years increasing funding for the development of efficient live-cell imaging techniques is also expected to boost the market. Over the forecast period, extensive research being carried out to develop microscopes of higher resolution is likely to boost the market. The growth of the market has been augmented by recent technological advances in microscopes. An inverted research-grade microscope, for example, has supported imaging of adherent cells and organelles and yields results of less than 5 um thickness for tissue sections. The overall industry trend is shifting towards automation, system integration, and maximizing microscope data generation. New developments also allow the cells to be imaged within a time range at spatial resolutions.

Restraint

High cost of high-content screening systems

High-content screening (HCS) tools are equipped with advanced functionalities and features and are therefore priced at a premium. As they have limited budgets, academic research laboratories find it hard to afford such high-priced tools. As they require multiple HCS systems in their R&D activities, the high price of these tools is also a concern for several pharmaceutical companies. In addition to the high cost of procurement, the total cost of ownership of these instruments is increased by maintenance costs and several other indirect costs. This is one of the major factors limiting the adoption of live cell imaging tools, particularly in emerging countries, in clinical and research applications.

Live Cell Imaging Market: Key Players

• Becton, Dickinson, and Company

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis
• Carl Zeiss AG
• GE Healthcare
• Leica Microsystems
• Olympus Corporation
• Molecular Devices LCC
• Nikon Corporation
• PerkinElmer Inc.
• Sigma-Aldrich Corporation
• Thermo Fisher Scientific Inc

Live Cell Imaging Market: Regions

Live Cell Imaging Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, APAC, and MENA.

Live Cell Imaging Market in North America held the largest market share of XX.X% in the year 2018 and will continue its lead through the forecast period. The North American market is largely driven by heavy funding for research and development activities in the region. Based on the rapid adoption of new research technologies, Europe closely follows the North American market. The Asia Pacific will be the fastest-growing market for live cell imaging because of widespread research and development outsourcing activities. In addition, Europe held a noteworthy bid due to the early appropriation of innovation. The emerging maturing population calls for focused research on perpetual diseases, such as malignancy, neurodegeneration, and cardiovascular diseases. This has encouraged the investigation and propelled microscopy of immature microorganisms.

Competitive Landscape:

The Live Cell Imaging market, which is highly competitive, consists of several major players such as Leica Microsystems, Becton, Dickinson, and Company, Olympus Corporation hold a substantial market share in the Live Cell Imaging market. Other players analyzed in this report are Carl Zeiss Meditec AG, and Thermo Fisher Scientific, Inc. among others.

The market competition has been stepped up by the availability of many players offering Live Cell Imaging. In September 2020, CytoSMART Technologies (Netherlands) launched CytoSMART Multi Lux, a remote live cell imaging system.

Live Cell Imaging Market is further segmented by region into:

• North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – the United States and Canada

• Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
• Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
• APAC Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and the Rest of APAC
• MENA Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA 

Live Cell Imaging Market report also contains analysis on:

Live Cell Imaging Market Segments:

• By Product:

  • Equipment
  • Consumable
  • Software
• By Technology:
  • Time-lapse Microscopy
  • Fluorescence recovery after photobleaching
  • Fluorescence resonance energy transfer
  • High content screening
  • Others
• By Application:
  • Cell Biology
  • Developmental Biology
  • Stem Cell & Drug Discovery
  • Others
• Live Cell Imaging Market Dynamics
• Live Cell Imaging Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints

Frequently Asked Questions (FAQ):